Darren Culshaw

Statistics

Publications

Citations

134

H-Index

Active since

2009

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Saint Barnabas Medical Center

Cubist Pharmaceuticals (United States)

Darren Culshaw is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in antibiotics, antimicrobial resistance, and infection control.

Top concepts

MedicineAntibioticsInfection ControlAntimicrobial ResistanceSurgeryMicrobiologyDrug ResistanceAntimicrobial TherapyClinical MicrobiologySurgical Site Infections

Publications per year

2009–2019

Publications

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation

Pamela Moise, Darren Culshaw, Annie Wong‐Beringer et al. · Clinical Therapeutics · 2015 · 57 citations

Antimicrobial Susceptibility, Antibiotics, Antimicrobial Stewardship +12

Daptomycin for the treatment of surgical site infections

Ronald S. Chamberlain, Darren Culshaw, Brian J. Donovan et al. · Surgery · 2009 · 31 citations

Surgical Site Infections, Antibiotics, Antibiotic Adjuvant +7

Daptomycin Therapy for Osteomyelitis: A Retrospective Study

Jason C Gallagher, Jennifer A. Huntington, Darren Culshaw et al. · BMC Infectious Diseases · 2012 · 24 citations · Full text

Ceftolozane-Tazobactam in the Treatment of Experimental Pseudomonas aeruginosa Pneumonia in Persistently Neutropenic Rabbits: Impact on Strains with Genetically Defined Mechanisms of Resistance

Vidmantas Petraitis, Rūta Petraitienė, Ethan Naing et al. · Antimicrobial Agents and Chemotherapy · 2019 · 12 citations · Full text

Tedizolid and Linezolid for Treatment of Acute Bacterial Skin and Skin Structure Infections of the Lower Extremity versus Non–Lower-Extremity Infections

Warren S. Joseph, Darren Culshaw, Steven Anuskiewicz et al. · Journal of the American Podiatric Medical Association · 2016 · 10 citations

1–5 of 5